Loading viewer...
investor_presentation
Format: PDF investor_presentation
First Quarter 2021 Earnings Call Presentation May 6, 2021
Earnings Call Presentation
This presentation (and oral statements regarding the subject matter of this presentation) includes forward-looking statements intended to
qualify under the “safe harbor” from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking
statements include any statements reflecting Quanta's expectations, intentions, strategies, assumptions, plans or beliefs about future
events or performance or that do not solely relate to historical or current facts. Forward-looking statements involve certain risks,
uncertainties and assumptions that are difficult to predict or beyond Quanta's control, and actual results may differ materially from those
expected, implied or forecasted by our forward-looking statements due to inaccurate assumptions and known and unknown risk and
uncertainties. For additional information concerning some of the risks, uncertainties, assumptions and other factors that could affect our
forward-looking statements, please refer to Quanta’s Annual Report on Form 10-K for the year ended December 31, 2020, Quarterly
Report on Form 10-Q for the quarter ended March 31, 2021 (when filed) and other documents filed with the Securities and Exchange
Commission, which are available on our website (www.quantaservices.com), as well as the risks, uncertainties and assumptions
identified in this presentation. Investors and analysts should not place undue reliance on Quanta’s forward-looking statements, which are
current only as of the date of this presentation. Quanta does not undertake and expressly disclaims any obligation to update or revise
any forward-looking statements to reflect events or circumstances after the date of this presentation or otherwise, and Quanta expressly
disclaims any written or oral statements made by any third party regarding the subject matter of this presentation.
Certain information may be provided in this presentation that includes financial measurements that are not required by, or presented in
accordance with, generally accepted accounting principles (GAAP). These non-GAAP measures should not be considered as
alternatives to GAAP measures, such as net income and cash flow provided by operating activities, and may be calculated differently
from, and therefore may not be comparable to, similarly titled measures used by other companies. For a reconciliation to the most
directly comparable GAAP financial measures, please refer to the accompanying reconciliation tables.
The information contained in this document has not been audited by any independent auditor. This presentation is prepared as a
convenience for securities analysts and investors and may be useful as a reference tool. Quanta may elect to modify the format or
Xenon Pharmaceuticals Investor Presentation — December 2021
investor_presentationinvestor_presentation
20 Pages
Xenon Pharmaceuticals Inc.
investor_presentation
Tolu Minerals Limited
discontinue publication at any time, without notice to securities analysts or investors.Notice to Investors
Call Participants and Agenda
President and Chief Executive Officer
Chief Financial Officer
Vice President, Investor Relations•Introduction and Forward-Looking
Preview truncated — download the full document for the complete content.
investor_presentation
55 Pages
investor_presentation
Tucows